These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23151126)

  • 1. A qualitative study evaluating experiences of a lifestyle intervention in men with prostate cancer undergoing androgen suppression therapy.
    Bourke L; Sohanpal R; Nanton V; Crank H; Rosario DJ; Saxton JM
    Trials; 2012 Nov; 13():208. PubMed ID: 23151126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lifestyle intervention in men with advanced prostate cancer receiving androgen suppression therapy: a feasibility study.
    Bourke L; Doll H; Crank H; Daley A; Rosario D; Saxton JM
    Cancer Epidemiol Biomarkers Prev; 2011 Apr; 20(4):647-57. PubMed ID: 21335510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lifestyle changes for improving disease-specific quality of life in sedentary men on long-term androgen-deprivation therapy for advanced prostate cancer: a randomised controlled trial.
    Bourke L; Gilbert S; Hooper R; Steed LA; Joshi M; Catto JW; Saxton JM; Rosario DJ
    Eur Urol; 2014 May; 65(5):865-72. PubMed ID: 24119318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, randomized pilot study evaluating the effects of metformin and lifestyle intervention on patients with prostate cancer receiving androgen deprivation therapy.
    Nobes JP; Langley SE; Klopper T; Russell-Jones D; Laing RW
    BJU Int; 2012 May; 109(10):1495-502. PubMed ID: 21933330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.
    Nair B; Wilt T; MacDonald R; Rutks I
    Cochrane Database Syst Rev; 2002; (1):CD003506. PubMed ID: 11869665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Individualized Diet and Exercise Adherence Pilot Trial (IDEA-P) in prostate cancer patients undergoing androgen deprivation therapy: study protocol for a randomized controlled trial.
    Focht BC; Lucas AR; Grainger E; Simpson C; Thomas-Ahner JM; Clinton SK
    Trials; 2014 Sep; 15():354. PubMed ID: 25199619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The feasibility of the Prostate cancer: Evidence of Exercise and Nutrition Trial (PrEvENT) dietary and physical activity modifications: a qualitative study.
    Shingler E; Hackshaw-McGeagh L; Robles L; Persad R; Koupparis A; Rowe E; Shiridzinomwa C; Bahl A; Martin RM; Lane JA
    Trials; 2017 Mar; 18(1):106. PubMed ID: 28264695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a lifestyle intervention on endothelial function in men on long-term androgen deprivation therapy for prostate cancer.
    Gilbert SE; Tew GA; Fairhurst C; Bourke L; Saxton JM; Winter EM; Rosario DJ
    Br J Cancer; 2016 Feb; 114(4):401-8. PubMed ID: 26766737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility, Acceptability, and Behavioral Outcomes from a Technology-enhanced Behavioral Change Intervention (Prostate 8): A Pilot Randomized Controlled Trial in Men with Prostate Cancer.
    Kenfield SA; Van Blarigan EL; Ameli N; Lavaki E; Cedars B; Paciorek AT; Monroy C; Tantum LK; Newton RU; Signorell C; Suh JH; Zhang L; Cooperberg MR; Carroll PR; Chan JM
    Eur Urol; 2019 Jun; 75(6):950-958. PubMed ID: 30638635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial.
    Denham JW; Joseph D; Lamb DS; Spry NA; Duchesne G; Matthews J; Atkinson C; Tai KH; Christie D; Kenny L; Turner S; Gogna NK; Diamond T; Delahunt B; Oldmeadow C; Attia J; Steigler A
    Lancet Oncol; 2019 Feb; 20(2):267-281. PubMed ID: 30579763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol.
    Spencer L; Rollo M; Hauck Y; MacDonald-Wicks L; Wood L; Hutchesson M; Giglia R; Smith R; Collins C
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):88-98. PubMed ID: 26447010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised controlled trial to evaluate the efficacy of a 6-month dietary and physical activity intervention for patients receiving androgen deprivation therapy for prostate cancer.
    O'Neill RF; Haseen F; Murray LJ; O'Sullivan JM; Cantwell MM
    J Cancer Surviv; 2015 Sep; 9(3):431-40. PubMed ID: 25916660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mobile Health App for Prostate Cancer Patients on Androgen Deprivation Therapy: Qualitative Usability Study.
    Nabi J; Cone EB; Vasavada A; Sun M; Kilbridge KL; Kibel AS; Berry DL; Trinh QD
    JMIR Mhealth Uhealth; 2020 Nov; 8(11):e20224. PubMed ID: 33141104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutrition therapy with high intensity interval training to improve prostate cancer-related fatigue in men on androgen deprivation therapy: a study protocol.
    Baguley BJ; Skinner TL; Leveritt MD; Wright OR
    BMC Cancer; 2017 Jan; 17(1):1. PubMed ID: 28049525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers and facilitators to healthy lifestyle and acceptability of a dietary and physical activity intervention among African Caribbean prostate cancer survivors in the UK: a qualitative study.
    Er V; Lane JA; Martin RM; Persad R; Chinegwundoh F; Njoku V; Sutton E
    BMJ Open; 2017 Oct; 7(10):e017217. PubMed ID: 29038181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial on the effectiveness of strength training on clinical and muscle cellular outcomes in patients with prostate cancer during androgen deprivation therapy: rationale and design.
    Thorsen L; Nilsen TS; Raastad T; Courneya KS; Skovlund E; Fosså SD
    BMC Cancer; 2012 Mar; 12():123. PubMed ID: 22458865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localised or locally advanced prostate cancer: an analysis of two randomised trials.
    D'Amico AV; Chen MH; de Castro M; Loffredo M; Lamb DS; Steigler A; Kantoff PW; Denham JW
    Lancet Oncol; 2012 Feb; 13(2):189-95. PubMed ID: 22112793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The provision of dietary and physical activity advice for men diagnosed with prostate cancer: a qualitative study of the experiences and views of health care professionals, patients and partners.
    Sutton E; Hackshaw-McGeagh LE; Aning J; Bahl A; Koupparis A; Persad R; Martin RM; Lane JA
    Cancer Causes Control; 2017 Apr; 28(4):319-329. PubMed ID: 28220328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifestyle interventions to improve the quality of life of men with prostate cancer: A systematic review of randomized controlled trials.
    Menichetti J; Villa S; Magnani T; Avuzzi B; Bosetti D; Marenghi C; Morlino S; Rancati T; Van Poppel H; Salvioni R; Valdagni R; Bellardita L
    Crit Rev Oncol Hematol; 2016 Dec; 108():13-22. PubMed ID: 27931831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptability of dietary and physical activity lifestyle modification for men following radiotherapy or radical prostatectomy for localised prostate cancer: a qualitative investigation.
    Hackshaw-McGeagh LE; Sutton E; Persad R; Aning J; Bahl A; Koupparis A; Millett C; Martin RM; Lane JA
    BMC Urol; 2017 Oct; 17(1):94. PubMed ID: 29017509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.